Biologic Therapies, Inc.

biologic therapies (bti) (www.biologictherapies.com) provides contemporary, pioneering technologies that enable surgeons to treat numerous orthopedic and other medical challenges. one such technology is bti’s unique bio-mac® bone marrow aspiration cannula, provisional patent number 61/445,624, u.s. patent pending. biologic therapies utilizes advanced medical research to open direct paths to technologies for regenerative cell therapy, which refers to using the body’s own regenerative cells that self-renew, have the ability to change into other types of cells, and accelerate healing. bti develops proprietary products and surgical protocols designed to optimize this type of therapy. bti’s state-of-the-art products are propelling the company as an industry leader by implementing a new ‘standard of care’ with its products and system technologies. regenerative medicine is a relatively new medical science that focuses on the body's own regenerative cells’ ability to speed healing within muscl